Verrast

por van der Poel, Henk G.
Publicado 2020

External Validation of a Prediction Model for Side-specific Extraprostatic Extension of Prostate Cancer at Robot-assisted Radical Prostatectomy

por Veerman, Hans, Heymans, Martijn W., van der Poel, Henk G.
Publicado 2022

Abandon the Label of Clinically Insignificant Prostate Cancer

por Mertens, Laura S., van Leeuwen, Pim J., van der Poel, Henk G.
Publicado 2022

Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410

por Veerman, Hans, Vis, André N., Donswijk, Maarten, van der Poel, Henk G.
Publicado 2022

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond

por Linder, Simon, van der Poel, Henk G, Bergman, Andries M, Zwart, Wilbert, Prekovic, Stefan
Publicado 2018

Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl)

por van Rossum, Huub H., van Winden, Lennart J., Bergman, Andries M., van der Poel, Henk G.
Publicado 2023

First Report of Two Cases of Acute Gastric Ischemia after Robot-Assisted Radical Cystectomy

por Grivas, Nikolaos, Horsch, Alexander D., Wit, Esther, Bruining, Annemarie, van Sandick, Johanna, van der Poel, Henk G.
Publicado 2021

The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression

por Wollersheim, Barbara M., Boekhout, Annelies H., van der Poel, Henk G., van de Poll‐Franse, Lonneke V., Schoormans, Dounya
Publicado 2019

Cost-utility analysis on robot-assisted and laparoscopic prostatectomy based on long-term functional outcomes

por Lindenberg, Melanie A., Retèl, Valesca P., van der Poel, Henk G., Bandstra, Ferdau, Wijburg, Carl, van Harten, Wim H.
Publicado 2022

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy

por Rybalov, Maxim, Ananias, Hildo J. K., Hoving, Hilde D., van der Poel, Henk G., Rosati, Stefano, de Jong, Igle J.
Publicado 2014

Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer

por Nevedomskaya, Ekaterina, Stelloo, Suzan, van der Poel, Henk G., de Jong, Jeroen, Wessels, Lodewyk F.A., Bergman, Andries M., Zwart, Wilbert
Publicado 2015

A testosterone-producing Leydig cell tumor metastasis during hormonal treatment of prostate cancer

por Stokkel, Laura, van der Poel, Henk G., Langbein, Sigrun I., Kerst, J. Martijn, de Jong, Jeroen, van Rhijn, Bas W. G.
Publicado 2020

Diagnostic Performance of a Magnetic Resonance Imaging-directed Targeted plus Regional Biopsy Approach in Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis

por Hagens, Marinus J., Fernandez Salamanca, Mar, Padhani, Anwar R., van Leeuwen, Pim J., van der Poel, Henk G., Schoots, Ivo G.
Publicado 2022

PREDICT: model for prediction of survival in localized prostate cancer

por Kerkmeijer, Linda G. W., Monninkhof, Evelyn M., van Oort, Inge M., van der Poel, Henk G., de Meerleer, Gert, van Vulpen, Marco
Publicado 2015

Three-way multiplexing in prostate cancer patients — combining a bimodal sentinel node tracer with multicolor fluorescence imaging

por Berrens, Anne-Claire, van Oosterom, Matthias N., Slof, Leon J., van Leeuwen, Fijs W. B., van der Poel, Henk G., Buckle, Tessa
Publicado 2022

Five Years of the CC-ERUS Fellowship: A Survey of the Experiences and Post-fellowship Work of the Fellows

por Beulens, Alexander J.W., Dell’Oglio, Paulo, Kiss, Hannah, Brinkman, Willem M., Larcher, Alessandro, Mottrie, Alexandre, Wagner, Christian, van der Poel, Henk G.
Publicado 2020

Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis

por Rafael, Tynisha S., Rotman, Jossie, Brouwer, Oscar R., van der Poel, Henk G., Mom, Constantijne H., Kenter, Gemma G., de Gruijl, Tanja D., Jordanova, Ekaterina S.
Publicado 2022

Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study

por Drost, Frank-Jan H., Rannikko, Antti, Valdagni, Riccardo, Pickles, Tom, Kakehi, Yoshiyuki, Remmers, Sebastiaan, van der Poel, Henk G., Bangma, Chris H., Roobol, Monique J.
Publicado 2018

Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study

por Donswijk, Maarten L., van Leeuwen, Pim J., Vegt, Erik, Cheung, Zing, Heijmink, Stijn W. T. P. J., van der Poel, Henk G., Stokkel, Marcel P. M.
Publicado 2020

Androgen receptor profiling predicts prostate cancer outcome

por Stelloo, Suzan, Nevedomskaya, Ekaterina, van der Poel, Henk G, de Jong, Jeroen, van Leenders, Geert JLH, Jenster, Guido, Wessels, Lodewyk FA, Bergman, Andries M, Zwart, Wilbert
Publicado 2015